Company intelligence / Profile preview

Beverly Hills Cancer Center

Beverly Hills, California, United States

Ownership: Private
Employees: ~112
Development stage: Other

Overview

Beverly Hills Cancer Center provides comprehensive oncology care, advanced radiation therapy (including IGRT, SBRT, and SCINTIX biology-guided radiotherapy), chemotherapy, integrative medicine, diagnostics, and participates in internationally recognized clinical trials. Recent SCINTIX clinical data reported 100% local control at nine months with no Grade 2 or higher adverse events for lung and bone tumors.

Therapeutic areas: Oncology
Modalities: RadiopharmaceuticalSmall molecule (for chemotherapy)Biologic (for immunotherapy)Monoclonal antibody (for specific regimens)Integrative medicine modalities (acupuncture, nutrition, etc.)
Industry: Academic Hospital/University/Research

Partnerships

RefleXion (radiotherapy technology/SCINTIX platform)

Beyond the preview

Go deeper on Beverly Hills Cancer Center.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Beverly Hills Cancer Center.

Explore the full profile